Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 17, 2017
Pharmacy Choice - Pharmaceutical News - Pfizer Receives China Food And Drug Administration Approval To Market Xeljanz - August 17, 2017

Pharmacy News Article

 3/16/17 - Pfizer Receives China Food And Drug Administration Approval To Market Xeljanz

NEW YORK CITY (dpa-AFX) - Pfizer China, a unit of Pfizer Inc. (PFE), said it has received approval from the Chinese Food and Drug Administration or CFDA to market its oral Janus kinase (JAK) inhibitor, Xeljanz or tofacitinib citrate, in China for the treatment of adult patients with moderately to severely active rheumatoid arthritis or RA, who have had an inadequate response or intolerance to methotrexate (MTX).

Xeljanz may be used in combination with MTX or other non-biologic disease-modifying antirheumatic drugs or DMARDs.

Xeljanz is the first JAK inhibitor approved for RA patients. JAK inhibitors act on the JAK pathway by working inside the cell to disrupt a signaling pathway believed to play a role in the inflammation associated with moderately to severely active RA.

"The introduction of the first oral JAK inhibitor for RA in China, Xeljanz, builds upon Pfizer's legacy as an innovator in inflammation and immunology and provides a new option for physicians and adult patients with moderately to severely active RA who may prefer an oral treatment for this chronic condition," said Guohong Shan, China Country Lead, Pfizer Innovative Health.



Copyright RTT News/dpa-AFX

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Aug 21: An Integrative Approach to Managing Arthritis
Aug 22: Men's Health
Aug 23: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Aug 24: Treatment of Parkinson's Disease and Comorbid Conditions
Aug 25: NSAIDs, Acetaminophen and Adjuvants in Pain Management
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415